SCHEMBL680611

SCHEMBL680611

CCCS(=O)(=O)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.70
HSD11B1 P28845 5/20 0.53
MAPT P10636 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 1/20 0.47
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
HTR6 P50406 1/20 0.46
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 2/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP3A4 P08684 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8909378 0.98 PSIP1 (0.67) PSIP1HSD11B1MAPTL3MBTL1TDP1
Fluoride SCHEMBL27365732 0.98 PSIP1 (0.67) PSIP1HSD11B1MAPTL3MBTL1TDP1
SCHEMBL21794433 0.90 PSIP1 (0.57) PSIP1HSD11B1MAPTL3MBTL1TDP1
SCHEMBL4629307 0.87 CYP2C9 (0.57) PSIP1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL28365756 0.87 PSIP1 (0.53) PSIP1HSD11B1MAPTL3MBTL1TDP1
SCHEMBL777886 0.86 PSIP1 (0.64) PSIP1HSD11B1MAPTL3MBTL1TDP1
SCHEMBL777601 0.85 PSIP1 (0.67) PSIP1HSD11B1MAPTL3MBTL1TDP1
Benzene SCHEMBL6390523 0.85 PSIP1 (0.61) PSIP1HSD11B1TDP1CYP2C9CYP2C19
SCHEMBL2445501 0.85 PSIP1 (0.61) PSIP1HSD11B1TDP1CYP2C9CYP2C19
SCHEMBL10616984 0.83 PSIP1 (0.59) PSIP1HSD11B1TDP1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118173889-A Electrolyte, lithium ion battery and electricity utilization device 清陶(昆山)能源发展集团股份有限公司 2024-06-11 CN claimed
CN-115939531-A High-voltage water-sulfone-based mixed electrolyte for water-based lithium ion battery and preparation method and application thereof 北京理工大学 2023-04-07 CN claimed
EP-2481760-B1 INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME CHINA PETROLEUM & CHEM CORP (CN) 2021-05-05 EP claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US claimed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 US claimed
CN-101034260-B Photosensitive resin composition DONGJIN SEMICOHEM CO LTD 2012-07-18 CN claimed
EP-1696912-A4 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2009-06-03 EP claimed
CN-101034260-A Photosensitive resin composition DONGJIN SEMICHEM CO LTD (KR) 2007-09-12 CN claimed
EP-1696912-A2 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M Innovative Properties Company (US) 2006-09-06 EP claimed
WO-2005079195-A2 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-09-01 WO claimed
US-6822097-B1 THIAZOLE-SUBSTITUTED QUINOLINE DERIVATIVES; ANTICARCINOGENIC AGENTS, ANTISTROKE AGENTS; APOPTOSIS AND CELL PROLIFERATION TREATMENT; NERVOUS SYSTEM DISORDERS AMGEN, INC. 2004-11-23 US claimed
EP-0602914-B1 Ink compositions for ink jet printing XEROX CORP (US) 1997-11-12 EP claimed
US-5393878-A Pyrimidine nucleosides having cyclopentafuran skeleton CIBA-GEIGY CORPORATION (US) 1995-02-28 US claimed
US-5319080-A Antiviral agents CIBA-GEIGY CORPORATION (US) 1994-06-07 US claimed
US-5300143-A Water soluble dye, sulfone, and amide or cyclic amine XEROX CORPORATION (US) 1994-04-05 US claimed
WO-1993013076-A1 GASTRIC ACID SECRETION-INHIBITING, AND GASTROCYTOPROTECTIVE PHARMACEUTICAL COMPOSITIONS, NOVEL FAMOTIDINE SALTS AND PROCESS FOR PREPARING SAME Richter Gedeon Vegyészeti Gyár Rt. (HU) 1993-07-08 WO claimed
US-12312301-B2 Organosulfur compounds MARIPOSA THERAPEUTICS LTD. (GB) 2025-05-27 US disclosed
US-20250105263-A1 ELECTRODE, METHOD FOR MANUFACTURING ELECTRODE, AND LITHIUM METAL BATTERY COMPRISING ELECTRODE IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) 2025-03-27 US disclosed
US-4130578-A Immunosuppressive dithiocarbanilates THE UPJOHN COMPANY (US) 1978-12-19 US disclosed
US-4028422-A SEX ATTRACTANTS FOR FLIES AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1977-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12312301-B2 Organosulfur compounds TST, MPST, F2 PSIP1 3254/4885HSD11B1 1958/4885MAPT 3099/4885
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR PSIP1 20/4885HSD11B1 2691/4885MAPT 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.